Stockscreener 앱 받기
13.72
7.55%
-1.1343
전일 마감가:
$14.85
열려 있는:
$14.61
하루 거래량:
1.41M
Relative Volume:
0.63
시가총액:
$1.45B
수익:
-
순이익/손실:
$-766.97M
주가수익비율:
-1.7906
EPS:
-7.66
순현금흐름:
$-646.43M
1주 성능:
-20.18%
1개월 성능:
-13.16%
6개월 성능:
-39.92%
1년 성능:
-72.56%
1일 변동 폭
$13.65
$14.81
1주일 범위
$13.65
$18.57
52주 변동 폭
$12.79
$54.98
바이오헤이븐 Stock (BHVN) Company Profile
명칭
Biohaven Ltd
전화
203-404-0410
주소
215 CHURCH STREET, NEW HAVEN, CT
BHVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
13.70 | 1.57B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.45 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.71 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.20 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.24 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.55 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
바이오헤이븐 Stock (BHVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 개시 | Citigroup | Buy |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-05-19 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-09-16 | 개시 | Jefferies | Buy |
| 2024-09-04 | 개시 | Bernstein | Outperform |
| 2024-07-24 | 개시 | Morgan Stanley | Overweight |
| 2024-02-16 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2023-12-22 | 개시 | H.C. Wainwright | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-01-24 | 개시 | SVB Securities | Outperform |
| 2023-01-04 | 개시 | JP Morgan | Overweight |
| 2022-12-02 | 개시 | BTIG Research | Buy |
| 2022-10-26 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 개시 | Piper Sandler | Overweight |
| 2022-08-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-05-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-08-03 | 재확인 | Canaccord Genuity | Buy |
| 2021-03-11 | 개시 | UBS | Buy |
| 2020-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-17 | 개시 | Cowen | Outperform |
| 2020-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2019-11-22 | 개시 | Wedbush | Outperform |
| 2019-06-25 | 재확인 | Canaccord Genuity | Buy |
| 2019-05-06 | 개시 | Goldman | Buy |
| 2019-04-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 재확인 | Needham | Buy |
| 2018-07-03 | 재확인 | Needham | Buy |
| 2018-07-02 | 재확인 | Needham | Buy |
| 2018-04-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 재확인 | Canaccord Genuity | Buy |
| 2017-12-15 | 개시 | Canaccord Genuity | Buy |
| 2017-10-03 | 재확인 | Needham | Buy |
모두보기
바이오헤이븐 주식(BHVN)의 최신 뉴스
Why hedge funds are buying Biohaven Ltd. stockWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Building trade automation scripts for Biohaven Ltd.Weekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
How Biohaven Ltd. stock benefits from global expansion2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Is Biohaven Ltd. stock a buy for dividend growthJuly 2025 Decliners & Verified Short-Term Plans - newser.com
What Fibonacci levels say about Biohaven Ltd. reboundJuly 2025 Breakouts & Safe Capital Growth Tips - newser.com
Will Biohaven Ltd. stock reach Wall Street targetsJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Is Biohaven Ltd. stock vulnerable to regulatory risksPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
How cyclical is Biohaven Ltd. Common Shares stock compared to rivalsMarket Movement Recap & Community Driven Trade Alerts - newser.com
How Biohaven Ltd. Common Shares stock trades in high volatility2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Can Biohaven Ltd. stock resist sector downturnsRecession Risk & Technical Pattern Recognition Alerts - newser.com
Predicting Biohaven Ltd. trend using moving averagesQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Biohaven stock plummets on FDA concerns despite Raymond James’ Strong Buy - Investing.com Australia
Optimistic Buy Rating for Biohaven Ltd. Amidst High-Risk PDUFA Decision on Troriluzole - TipRanks
Optimistic Buy Rating on Biohaven Ltd. Amidst High-Risk, High-Reward Potential - TipRanks
FDA’s ‘surprising’ uniQure reversal drags down Biohaven - TipRanks
Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears - ts2.tech
Earnings visualization tools for Biohaven Ltd.Insider Selling & Consistent Profit Alerts - newser.com
Market reaction to Biohaven Ltd.’s recent newsWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Why Biohaven Ltd. stock is favored by pension fundsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Biohaven Ltd. stock chart pattern explained2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Is a relief rally coming for Biohaven Ltd. holdersBear Alert & Daily Market Momentum Tracking - newser.com
Has Biohaven Ltd. formed a bullish divergence2025 Support & Resistance & Low Risk Profit Maximizing Plans - newser.com
Will Biohaven Ltd. stock gain from government policiesCPI Data & Weekly Return Optimization Plans - newser.com
Relative strength of Biohaven Ltd. in sector analysisMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com
Will Biohaven Ltd. stock gain from strong economyWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Will Biohaven Ltd. stock remain a Wall Street favoriteTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Biohaven Ltd. stock trend outlook and recovery pathIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Does Biohaven Ltd. fit your quant trading modelBuy Signal & Weekly Stock Performance Updates - newser.com
Biohaven Ltd. (NYSE:BHVN) institutional owners may be pleased with recent gains after 66% loss over the past year - Yahoo Finance
Is Biohaven Ltd. Common Shares stock a contrarian opportunityJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
바이오헤이븐 (BHVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
0.86%
자본화:
|
볼륨(24시간):